Data / Form D filings / Silence Therapeutics plc
Silence Therapeutics plc: Form D filings
Silence Therapeutics plc, a biotechnology company in London, United Kingdom, filed 4 Form D notices with the SEC between 2010 and 2021. The latest, on February 18, 2021, reports $45.5 million sold of a $45.5 million offering to 12 investors.
Find out what Silence Therapeutics plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 72 HAMMERSMITH ROAD, London, United Kingdom, W14 8
- Phone
- 44-0-20-3457 6900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1479615
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 18, 2021 | New notice | $45,499,905 | $45,499,905 | $0 | 12 | Feb 4, 2021 | sec.gov |
| Jan 5, 2010 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
| Jan 5, 2010 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
| Jan 5, 2010 | New notice | $8,500,000 | $0 | $8,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Ede-Golightly | Director | |
| Alistair Gray | Director | |
| Craig Tooman | Executive Officer | |
| Dave Lemus | Director | |
| Giles Campion | Executive Officer | |
| Romano Steven | Director | |
| Michael H. Davidson | Director | |
| Mark Rothera | Executive Officer, Director | |
| Iain Ross | Director | |
| Barbara Ruskin | Executive Officer |
Every Form D from the week of Feb 15, 2021 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Silence Therapeutics plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.